Wyeth &
Pfizer Inc | Update Date: 02/06/09 |
| Date Announced: 01/26/09 |
| Value (million $USD): 67.29 billion U.S. Dollar |
|
| Status: Pending | |
| TRANSACTION DETAILS |
|---|
| Date Announced | 01/26/09 | | |
| Date Originally Announced | 01/23/09 | | |
| Format | Merger | Acquisition techniques | Rumored Deal |
| Attitude | Friendly | Agency | Justice Department; Federal Trade Commission; Unspecified Regulatory Auth. |
| Value | 67.29 billion U.S. Dollar | Advisor Fees | n/a |
| SYNOPSIS |
|---|
| US - Pfizer Inc (PI) definitively agreed to acquire all the outstanding common stock of Wyeth (WY), a manufacturer and wholesaler of pharmaceuticals, in a transaction valued at $67.286 bil. PI offered $33 in cash and 0.985 common shares per WY share. Based on PI's closing stock price of $17.45 on January 23, the last full trading day prior to the announcement, each WY share was valued at $17.188. The transaction was subject to customary closing conditions, shareholder and regulatory approvals. Originally, PI was rumored to be planning to acquire all the outstanding common stock of WY. |
| TARGET |
|---|
| Name | Wyeth (WYE) |
| Industries | Biological products, except diagnostic substances; Perfumes, cosmetics, and other toilet preparations; Surgical and medical instruments and apparatus; Measuring&controlling devices; Prepared animal feeds, except for dogs and cats; Canned specialties; Food preparations, nec; Potato chips, corn chips, and similar snacks; Commercial physical and biological research; Drugs, drug proprietaries, and druggists' sundries |
| City | Madison |
| State | NJ |
| Nation | United States |
| Incorporated in | DE |
| Public Status | Public |
| Business Description | Wyeth,a pharmaceutical manufacturing firm, headquartered in New Jersey, USA with locations in Europe, Africa, Asia and Australia. The company's brands include Advil, Caltrate, ChapStick, Dimetapp, Hetacin-K, Lo/Ovral Tablets, etc.The company specifically manufactures female oral contraceptives, cardiovascular therapies, mental health agents, anti-inflammatory drugs, hospitable injectables, diabetic therapeutics, cold and allergy products, influenza, cholera, typhoid, diphteria, adenovirus and other vaccines and biologicals, oral hygienes, hemorrhoidal and asthama products, lip care, medicated shampoos, topical analgesics, natural sedatives, disposable syringes and needles, tube, catheter and chest drainage products, obstetrical monitoring products, cardiopulmonary instrumentation, clinical laboratory stems, enteral feeding systems, wound care dressings, animal health cares, poultry feed additives and medical supplies and produce entrees and side dishes, such as Chef Boyardee, condiments and snacks. Founded in 1410. |
| Advisors | Morgan Stanley; Evercore Partners |
| Target Sales | 23.25 billion U.S. Dollar |
|
| ACQUIROR |
|---|
| Name | Pfizer Inc (PFE) |
| Industries | Medicinal chemicals and botanical products; Biological products, except diagnostic substances; Drugs, drug proprietaries, and druggists' sundries |
| City | New York |
| State | NY |
| Nation | United States |
| Incorporated in | DE |
| Public Status | Public |
| Business Description | Pfizer Inc, headquartered in New York, New York, manufactures and wholesales prescription medicines and other pharmaceuticals for humans and animals. The Group operates in three segments: Human Health segment, Consumer Healthcare segment and Animal Health segment. The company was founded in 1849. |
| Advisors | Bank of America Merrill Lynch; Goldman Sachs & Co; JP Morgan & Co Inc; Barclays PLC; Citi |
| Acquiror Sales | 48.84 billion U.S. Dollar |
|
 |
|
